Search
for

    Glossary Sertraline

    medication used to treat depression and anxiety disorders

    Sertraline, commonly known by the brand name Zoloft, is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat depression, anxiety disorders, and other mood disorders. It works by increasing the levels of serotonin in the brain, which can help improve mood, sleep, and energy levels.

    Sort by

    Research 30 of 145

    1. Fluoxetine- and Sertraline-Related Hair Loss in a Teenager: A Case Report Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology · 2013 · 5 citations
    2. Diffuse Hair Loss Induced by Sertraline Use Case reports in psychiatry · 2015 · 3 citations
    3. Hair Loss Associated with Sertraline: Two Case Reports and Review Iranian journal of psychiatry and behavioral sciences · 2016 · 1 citations
    4. Hair Loss Associated with Sertraline: Two Case Reports and Review Iranian journal of psychiatry and behavioral sciences · 2016
    5. Comparación de los efectos del D-004, imipramina y sertralina en el modelo de nado forzado en ratones Comparative effects of D-004, Imipramine and Sertraline in the forced swimming test in mice DOAJ (DOAJ: Directory of Open Access Journals) · 2012
    6. Scalp Dysesthesia Archives of Dermatology · 1998 · 63 citations
    7. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs) Pharmacoepidemiology and drug safety · 2006 · 25 citations
    8. Alopecia: A Less Known but Devastating Side Effect of Serotonin Reuptake Inhibitors ScholarWorks - WMU (Western Michigan University) · 2017
    9. Details always tell a big story: Importance of physical symptoms in evaluation of secondary causes of depression Psychiatry and clinical neurosciences · 2013
    10. Anorexia Nervosa and Gender Dysphoria: A Clinical Case European Psychiatry · 2022
    11. Midazolam Ameliorates the Behavior Deficits of a Rat Posttraumatic Stress Disorder Model through Dual 18 kDa Translocator Protein and Central Benzodiazepine Receptor and Neurosteroidogenesis PLoS ONE · 2014 · 56 citations
    12. A CASE REPORT OF PARANOID DELUSION WITH VENLAFAXINE USE Journal of the American Geriatrics Society · 2003 · 8 citations
    13. The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products Journal of Mind and Medical Sciences · 2020 · 2 citations
    14. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025
    15. And next… Adnexa: Frontal Fibrosing Alopecia 2015
    16. Reporting on Adverse Clinical Events Clin-Alert · 2010
    17. Can male-pattern baldness be prevented? The Lancet · 1997 · 3 citations
    18. A Review on Drug Induced Alopecia International Journal of Science and Research (IJSR) · 2022
    19. News in brief The Lancet · 1997
    20. First reboxetine trial results reported The Lancet · 1997
    21. The Neurobiology of Sexual Function Archives of General Psychiatry · 2000 · 393 citations
    22. Hair Loss in Women The New England Journal of Medicine · 2007 · 129 citations
    23. Adverse effects of common medications on male fertility Nature Reviews Urology · 2015 · 77 citations
    24. DRUG‐ASSOCIATED ALOPECIA International Journal of Dermatology · 1995 · 63 citations
    25. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors Journal of The American Academy of Dermatology · 2006 · 55 citations
    26. Drug-induced acne Clinics in Dermatology · 2016 · 52 citations
    27. Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management The Neurologist · 2002 · 45 citations
    28. Adverse Cutaneous Reactions to Antidepressants American Journal of Clinical Dermatology · 2002 · 44 citations
    29. Psychocutaneous disease Journal of The American Academy of Dermatology · 2017 · 38 citations
    30. Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial The Journal of Sexual Medicine · 2014 · 36 citations